Translational Development Acquisition (TDAC) Total Current Liabilities (2023 - 2026)
Translational Development Acquisition's (TDAC) quarterly Total Current Liabilities came in at $861085.0 in Q1 2026, up 166.67% YoY from $322900.0 in Q1 2025, and up 58.27% on a QoQ basis from $544073.0 in Q4 2025.
Translational Development Acquisition (TDAC) Total Current Liabilities (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDAC) has 4 years of Total Current Liabilities data on file, last reported at $861085.0 in Q1 2026.
- Quarterly Total Current Liabilities rose 166.67% year-over-year to $861085.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $861085.0 (up 166.67% YoY) and the FY2025 annual result came in at $544073.0, up 158.71% from the prior year.
- Total Current Liabilities improved to $861085.0 in Q1 2026, from $544073.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $861085.0 in Q1 2026 to a low of $210303.0 in Q4 2024.
- A 4-year average of $450795.3 and a median of $422845.0 in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities plunged 58.74% — and 2026, when it soared 166.67%.
- Tracing TDAC's Total Current Liabilities over 4 years: stood at $509679.0 in 2023, then sank by 58.74% to $210303.0 in 2024, then surged by 158.71% to $544073.0 in 2025, then jumped by 58.27% to $861085.0 in 2026.
- The last three Total Current Liabilities figures came in at $861085.0 (Q1 2026), $544073.0 (Q4 2025), and $422845.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 281,435.00 |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 644,574.00 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | - |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 2.38 Mn |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 20,057.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | 3.69 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 22.16 Mn |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | 748,633.00 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | 2.41 Mn |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | 1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861,085.00 |
| Dec 31, 2025 | 544,073.00 |
| Sep 30, 2025 | 422,845.00 |
| Jun 30, 2025 | 284,682.00 |
| Mar 31, 2025 | 322,900.00 |
| Dec 31, 2024 | 210,303.00 |
| Dec 31, 2023 | 509,679.00 |